Drug-Induced Thrombocytopenia Due to Nintedanib during Treatment of Idiopathic Pulmonary Fibrosis

Nintedanib is a tyrosine kinase inhibitor that was approved for the treatment of patients with idiopathic pulmonary fibrosis in 2014. The most common side effect of Nintedanib is diarrhea, and thrombocytopenia is a rare side effect of Nintedanib. The exact mechanism is unknown, and the literature la...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumic, Igor, Charokopos, Antonios, Parmar, Angadabir, Grant, Christopher R., Cosiquien, Ronin Joshua S., Dagnon da Silva, Marilia, Petcu, Emilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224178/
https://www.ncbi.nlm.nih.gov/pubmed/37241231
http://dx.doi.org/10.3390/medicina59050999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224178/
https://www.ncbi.nlm.nih.gov/pubmed/37241231
http://dx.doi.org/10.3390/medicina59050999

Ejemplares similares